Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, National and Kapodistrian University of Athens, 15Β, Ag. Thoma str., 115 27, Athens, Greece.
Clin Exp Nephrol. 2019 Jun;23(6):782-791. doi: 10.1007/s10157-019-01706-9. Epub 2019 Feb 8.
Acute kidney injury constitutes a major complication of cardiac surgery in pediatric patients. The present meta-analysis aims to accumulate current literature and assess the efficacy of pharmacological interventions in preventing postoperative renal dysfunction after congenital heart surgery.
Literature search was conducted using Medline (1966-2018), Scopus (2004-2018), Cochrane Central Register of Controlled Trials CENTRAL (1999-2018), Clinicaltrials.gov (2008-2018), and Google Scholar (2004-2018) databases. Statistical analysis was performed with Review Manager 5.3 and R 3.4.3.
Meta-analysis included 14 studies, with a total of 2,625 patients. AKI incidence was significantly lower in the dexmedetomidine (OR 0.49, 95% CI [0.28-0.87]) and acetaminophen (OR 0.43, 94% CI [0.28-0.67]) groups, while no difference was present in patients receiving corticosteroid (OR 1.16, 95% CI [0.69-1.95]), fenoldopam (OR 0.47, 95% CI [0.22-1.02]), or aminophylline (OR 0.98, 95% CI [0.29-3.34]). Network meta-analysis proposed that dexmedetomidine had the greatest probability (44.5%) to rank first, although significant overlap with the other treatments was observed.
The present meta-analysis suggests that no firm evidence exists about the protective role of pharmacological interventions in the pediatric population. Future randomized controlled trials should clarify the effectiveness of dexmedetomidine and acetaminophen and indicate the optimal protocol to be applied, to protect renal function in the perioperative setting.
急性肾损伤是小儿心脏手术后的主要并发症。本荟萃分析旨在汇总现有文献,评估药物干预措施预防先天性心脏手术后肾功能障碍的疗效。
使用 Medline(1966-2018 年)、Scopus(2004-2018 年)、Cochrane 中央对照试验注册中心 CENTRAL(1999-2018 年)、Clinicaltrials.gov(2008-2018 年)和 Google Scholar(2004-2018 年)数据库进行文献检索。使用 Review Manager 5.3 和 R 3.4.3 进行统计分析。
荟萃分析纳入 14 项研究,共 2625 例患者。右美托咪定(OR 0.49,95%CI [0.28-0.87])和对乙酰氨基酚(OR 0.43,94%CI [0.28-0.67])组的 AKI 发生率显著降低,而接受皮质类固醇(OR 1.16,95%CI [0.69-1.95])、芬诺多泮(OR 0.47,95%CI [0.22-1.02])或氨茶碱(OR 0.98,95%CI [0.29-3.34])治疗的患者之间无差异。网络荟萃分析提出,右美托咪定具有排名第一的最大可能性(44.5%),尽管与其他治疗方法存在显著重叠。
本荟萃分析表明,目前尚无确凿证据表明药物干预在儿科人群中具有保护作用。未来的随机对照试验应阐明右美托咪定和对乙酰氨基酚的有效性,并指出应用的最佳方案,以保护围手术期的肾功能。